Literature DB >> 17057093

Immunostimulatory activity of recombinant Mycobacterium bovis BCG that secretes major membrane protein II of Mycobacterium leprae.

Masahiko Makino1, Yumi Maeda, Katsuya Inagaki.   

Abstract

We previously demonstrated that major membrane protein II (MMP-II) is one of the immunodominant antigens (Ags) of Mycobacterium leprae capable of activating T cells through Toll-like receptor 2. Based on the observation that Mycobacterium bovis BCG secreting a 30-kDa protein offered better protection against tuberculosis, we constructed a recombinant BCG strain (BCG-SM) that secretes MMP-II to improve the potency of BCG against leprosy. The secreted MMP-II protein from BCG-SM stimulated monocyte-derived dendritic cells (DC) to produce interleukin-12. DC infected with BCG-SM expressed MMP-II on their surfaces, and MMP-II expression was suppressed by the pretreatment of DC with chloroquine. These results indicated that secreted MMP-II was processed by DC for higher expression levels on their surfaces. In addition, BCG-SM phenotypically activated DC and induced higher expression levels of major histocompatibility complex, CD86, and CD83 Ags on DC than did vector control BCG (BCG-pMV). The DC infected with BCG-SM more efficiently stimulated naïve and memory CD4+ T cells and memory CD8+ T cells to produce gamma interferon than did those infected with BCG-pMV. However, naïve CD8+ T cells were significantly activated only when they were stimulated with BCG-SM-infected DC. When CD8+ T cells were cocultured with BCG-SM-infected DC, the proportion of perforin-producing T cells was significantly higher than that in cells cocultured with BCG-pMV-infected DC. Moreover, MMP-II-specific memory T cells were more efficiently produced in mice inoculated with BCG-SM than in mice inoculated with BCG-pMV. Taken together, these results indicate that BCG capable of secreting the immunodominant Ag is more potent in the stimulation of T cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17057093      PMCID: PMC1695513          DOI: 10.1128/IAI.00878-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

Review 1.  Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity.

Authors:  Y J Liu
Journal:  Cell       Date:  2001-08-10       Impact factor: 41.582

2.  Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model.

Authors:  M A Horwitz; G Harth; B J Dillon; S Maslesa-Galic'
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

3.  Leprosy elimination campaigns: impact on case detection.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2003-01-17

4.  Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis.

Authors:  Florian Winau; Stephan Weber; Subash Sad; Juana de Diego; Silvia Locatelli Hoops; Bernadette Breiden; Konrad Sandhoff; Volker Brinkmann; Stefan H E Kaufmann; Ulrich E Schaible
Journal:  Immunity       Date:  2006-01       Impact factor: 31.745

5.  Dendritic cells are host cells for mycobacteria in vivo that trigger innate and acquired immunity.

Authors:  Xinan Jiao; Richard Lo-Man; Pierre Guermonprez; Laurence Fiette; Edith Dériaud; Sophie Burgaud; Brigitte Gicquel; Nathalie Winter; Claude Leclerc
Journal:  J Immunol       Date:  2002-02-01       Impact factor: 5.422

6.  Detection of Toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patients.

Authors:  T J Kang; G T Chae
Journal:  FEMS Immunol Med Microbiol       Date:  2001-07

7.  Classification of leprosy according to immunity. A five-group system.

Authors:  D S Ridley; W H Jopling
Journal:  Int J Lepr Other Mycobact Dis       Date:  1966 Jul-Sep

8.  Multidrug resistant Mycobacterium leprae from patients with leprosy.

Authors:  S Maeda; M Matsuoka; N Nakata; M Kai; Y Maeda; K Hashimoto; H Kimura; K Kobayashi; Y Kashiwabara
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

9.  An in vitro model for the lepromatous leprosy granuloma: fate of Mycobacterium leprae from target macrophages after interaction with normal and activated effector macrophages.

Authors:  Deanna A Hagge; Nashone A Ray; James L Krahenbuhl; Linda B Adams
Journal:  J Immunol       Date:  2004-06-15       Impact factor: 5.422

10.  Mycobacterium leprae infection in monocyte-derived dendritic cells and its influence on antigen-presenting function.

Authors:  Ken Hashimoto; Yumi Maeda; Hiroaki Kimura; Koichi Suzuki; Akihiro Masuda; Masanori Matsuoka; Masahiko Makino
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

View more
  6 in total

Review 1.  Advances and hurdles on the way toward a leprosy vaccine.

Authors:  Malcolm S Duthie; Thomas P Gillis; Steven G Reed
Journal:  Hum Vaccin       Date:  2011-11-01

2.  Efficient activation of human T cells of both CD4 and CD8 subsets by urease-deficient recombinant Mycobacterium bovis BCG that produced a heat shock protein 70-M. tuberculosis-derived major membrane protein II fusion protein.

Authors:  Tetsu Mukai; Yumiko Tsukamoto; Yumi Maeda; Toshiki Tamura; Masahiko Makino
Journal:  Clin Vaccine Immunol       Date:  2013-10-23

3.  Immunostimulatory activity of major membrane protein II from Mycobacterium tuberculosis.

Authors:  Yumiko Tsukamoto; Masumi Endoh; Tetsu Mukai; Yumi Maeda; Toshiki Tamura; Masanori Kai; Masahiko Makino
Journal:  Clin Vaccine Immunol       Date:  2010-12-15

4.  Inhibition of the multiplication of Mycobacterium leprae by vaccination with a recombinant M. bovis BCG strain that secretes major membrane protein II in mice.

Authors:  Y Maeda; T Tamura; M Matsuoka; M Makino
Journal:  Clin Vaccine Immunol       Date:  2009-08-12

Review 5.  Combination chemoprophylaxis and immunoprophylaxis in reducing the incidence of leprosy.

Authors:  Malcolm S Duthie; Marivic F Balagon
Journal:  Risk Manag Healthc Policy       Date:  2016-04-27

6.  Polyclonal activation of naïve T cells by urease deficient-recombinant BCG that produced protein complex composed of heat shock protein 70, CysO and major membrane protein-II.

Authors:  Yumiko Tsukamoto; Yumi Maeda; Toshiki Tamura; Tetsu Mukai; Masahiko Makino
Journal:  BMC Infect Dis       Date:  2014-04-02       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.